Korean FDA Approves Mazor Robotics' Renaissance Robotic PlatformWritten by Jaimie Oh | June 13, 2012
Mazor Robotics, a developer of surgical robots and complementary products, announced that its Korean distributor, BR Holdings, received clearance from the Korean Food & Drug Administration to market Mazor's Renaissance surgical guidance system for spine procedures.
"Korean spine surgeons performed 120,000 cases in 2008, reflecting 18 percent annual growth from 2003; per capita, it is the second largest spine surgery market globally, and the country adopts new technologies with enthusiasm," said Ori Hadomi, CEO of Mazor. "As an example, the Korean healthcare system currently supports 36 da Vinci surgical robots. We expect Korea to be a very strong market for our surgical robots and serve as a gateway to the Asia Pacific region, as it has in the past for other robotic technologies."
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.